Disruption of exon definition produces a dominant-negative growth hormone isoform that causes somatotroph death and IGHD II
- 29 April 2003
- journal article
- research article
- Published by Springer Nature in Human Genetics
- Vol. 113 (2) , 140-148
Abstract
Isolated growth hormone deficiency type II (IGHD II) is characterized by short stature due to dominant-negative mutations of the human growth hormone gene (GH1). Most of the known mutations responsible for IGHD II cause aberrant splicing of GH1 transcripts. We have recently shown that mutations that cause exon 3 skipping and produce a dominant-negative 17.5-kDa isoform in humans also cause a dose-dependent disruption of GH secretory vesicles when expressed in GC cells and transgenic mice. We show here that overexpression of the dominant-negative 17.5-kDa isoform also destroys the majority of somatotrophs, leading to anterior pituitary hypoplasia in transgenic mice. It is, therefore, important to understand the regulation of GH1 splicing and why its perturbation causes IGHD II. We demonstrate that dual splicing enhancers are required to ensure exon 3 definition to produce full-length 22-kDa hormone. We also show that splicing enhancer mutations that weaken exon 3 recognition produce variable amounts of the 17.5-kDa isoform, a result which could potentially explain the clinical variability observed in IGHD II. Non-canonical splicing mutations that disrupt splicing enhancers, such as those illustrated here, demonstrate the importance of enhancer elements in regulating alternative splicing to prevent human disease.Keywords
This publication has 33 references indexed in Scilit:
- Autosomal Dominant Growth Hormone Deficiency Disrupts Secretory Vesiclesin Vitroandin Vivoin Transgenic MiceEndocrinology, 2003
- Listening to silence and understanding nonsense: exonic mutations that affect splicingNature Reviews Genetics, 2002
- The HUGO Gene Nomenclature Committee (HGNC)Human Genetics, 2001
- A Secreted Fluorescent Reporter Targeted to Pituitary Growth Hormone Cells in Transgenic MiceEndocrinology, 2000
- Autosomal Dominant Growth Hormone (GH) Deficiency Type II: The Del32–71-GH Deletion Mutant Suppresses Secretion of Wild-Type GH1Endocrinology, 2000
- A novel mutation at the donor splice site of intron 3 of the GH-I gene in a patient with isolated growth hormone deficiencyGrowth Hormone & IGF Research, 1999
- A systematic analysis of the factors that determine the strength of pre‐mRNA splicing enhancersThe EMBO Journal, 1998
- The molecular genetics of growth hormone deficiencyHuman Genetics, 1998
- The 20,000 Da variant of human growth hormone does not bind to growth hormone receptors in human liverMolecular and Cellular Endocrinology, 1990
- RNA splice junctions of different classes of eukaryotes: sequence statistics and functional implications in gene expressionNucleic Acids Research, 1987